Compare Ginkgo Bioworks Holdings Inc (DNA) vs Mongodb Inc (MDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Mongodb Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Mongodb Inc trades at $435.09 (market cap $35.32B). The key difference: Mongodb Inc is far larger — about 69.8× Ginkgo Bioworks Holdings Inc's market cap, and Mongodb Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | MDB | |
|---|---|---|
Market Cap | $505.73M | $35.32B |
Sector | Health | Technology |
52-Week High | $16.14 | $440.25 |
52-Week Low | $5.48 | $204.37 |
Enterprise Value | $607.68M | $32.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
